Form 4: Perrigo Executive Svend Andersen Reports Share Acquisitions and RSU Activity

EVP and President of Consumer Self-Care International at Perrigo, Svend Andersen, reports acquisition of ordinary shares and activity related to Restricted Stock Units (RSUs).

Summary

• Svend Andersen, EVP & President CHCI at Perrigo Co. plc, filed a Form 4 detailing changes in beneficial ownership.
• On March 5, 2024, Andersen acquired 3,411 ordinary shares at a price of $27.26 per share.
• Additionally, Andersen acquired 19,445 ordinary shares at $27.26.
• Following these transactions, Andersen directly owns 91,597 ordinary shares.
• Andersen also indirectly owns 13,683 ordinary shares through The Panel ApS.
• The filing also reports activity related to Restricted Stock Units (RSUs), with 3,411 RSUs converted to ordinary shares.
• Victor Torres, acting as attorney-in-fact, signed the report on March 7, 2024.
• An exhibit includes a Power of Attorney document, effective from September 29, 2020, granting Todd W. Kingma, Ryan Bradtke, and Victor Torres the authority to execute and file Forms 3, 4, and 5 on Andersen's behalf.

Sentiment

Score: 6

Explanation: The document is a routine SEC filing detailing insider transactions. It doesn't inherently convey positive or negative sentiment, but rather provides factual information. The acquisitions could be seen as a mildly positive signal.

Positives

• The filing indicates an executive's increased investment in the company through share acquisitions.
• The Power of Attorney ensures continued compliance with SEC regulations.

Industry Context

Form 4 filings are standard practice for company insiders to report transactions in their company's securities, providing transparency to investors.

Comparison to Industry Standards

• Executive compensation packages often include stock options and restricted stock units to align management's interests with those of shareholders.
• Monitoring insider transactions is a common practice among investors to gauge management's confidence in the company's future prospects.
• Perrigo's executive compensation practices are likely benchmarked against those of its peers in the consumer healthcare industry, such as Johnson & Johnson, Procter & Gamble, and Unilever.

Stakeholder Impact

• Shareholders may view the executive's share acquisitions as a positive sign of confidence in the company's future performance.
• The filing ensures transparency and compliance with SEC regulations, which benefits all stakeholders.

Key Dates